ChemicalBook--->CAS DataBase List--->23452-98-4

23452-98-4

23452-98-4 Structure

23452-98-4 Structure
IdentificationBack Directory
[Name]

1A,1B-DIHOMO PROSTAGLANDIN E1
[CAS]

23452-98-4
[Synonyms]

1a,1b-dihomo PGE1
YMDDELUTDBQEMT-QZCLESEGSA-N
1A,1B-DIHOMO PROSTAGLANDIN E1
9-oxo-11α,15S-dihydroxy-1a,1b-dihomo-prost-13E-en-1-oic acid
9-OXO-11ALPHA,15S-DIHYDROXY-1A,1B-DIHOMO-PROST-13E-EN-1-OIC ACID
[Molecular Formula]

C22H38O5
[MDL Number]

MFCD00797640
[MOL File]

23452-98-4.mol
[Molecular Weight]

382.53
Chemical PropertiesBack Directory
[Boiling point ]

550.1±50.0 °C(Predicted)
[density ]

1.104±0.06 g/cm3(Predicted)
[storage temp. ]

Store at -20°C
[solubility ]

DMF: >100 mg/ml; DMSO: >50 mg/ml; Ethanol: >50 mg/ml; PBS pH 7.2: >1.6 mg/ml
[form ]

Liquid
[pka]

4.78±0.10(Predicted)
[color ]

Colorless to light yellow
Safety DataBack Directory
[Symbol(GHS) ]

Flame (GHS02)Exclamation Mark (GHS07)Health Hazard (GHS08)
GHS02,GHS07,GHS08
[Signal word ]

Danger
[Hazard statements ]

H225-H319-H361-H336
[Precautionary statements ]

P201-P202-P210-P240-P241-P242-P243-P261-P264-P271-P280-P303+P361+P353-P304+P340-P305+P351+P338-P308+P313-P312-P337+P313-P370+P378-P403+P233-P403+P235-P405-P501
Hazard InformationBack Directory
[Description]

Prostaglandin E1 (PGE1) is not a major naturally occurring PG, but is widely administered clinically for several indications including peripheral occlusive vascular disease, erectile dysfunction, and in neonatal cardiology.1,2 COX metabolism of the unusual fatty acid 10,13,16-docosatrienoic acid yields 1a,1b-dihomo PGE1. This rare metabolite has been recovered from incubations of whole sheep seminal vesicles, but has not been reported in humans.3 In ex vivo preparations of rat aorta and rat PRP, 1a,1b-dihomo PGE1 was found to be much less active than PGE1 itself.4
[Uses]

1a,1b-Dihomo prostaglandin E1 (1a,1b-Dihomo PGE1) is a class of prostaglandin compound[1].
[Definition]

ChEBI: 1a,1b-dihomo-PGE1 is a prostanoid.
[References]

1. Virag, R., Shoukry, K., Floresco, J., et al. Intracavernous self-injection of vasoactive drugs in the treatment of impotence: 8-Year experience with 615 cases J. Urol. 145(2),287-293(1991).
2. Hoshi, K. Approved indications of lipo-PGE1 in Japan Adv. Drug Deliv. Rev. 20(2-3),171-176(1996).
3. Samel, N., and Maxey, K.M. Personal Communication ,(2003).
4. Kloeze, J. Relationship between chemical structure and platelet-aggregation activity of prostaglandins Biochim. Biophys. Acta 187(3),285-292(1969).
23452-98-4 suppliers list
Company Name: Quality Control Solutions Ltd.  
Telephone: 0755-66853366 13670046396
Website: www.qcsrm.com
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Telephone: 15026964105
Website: www.shyuanye.com
Company Name: Shenzhen Polymeri Biochemical Technology Co., Ltd.  
Telephone: +86-400-002-6226
Website: https://www.rrkchem.com
Company Name: ChemeGen(Shanghai) Biotechnology Co.,Ltd.  
Telephone: 18818260767
Website: http://www.chemegen.com
Company Name: TargetMol Chemicals Inc.  
Telephone: 4008200310 15002144251
Website: https://www.targetmol.cn/
Company Name: Shanghai Yifei Biotechnology Co. , Ltd.  
Telephone: 021-65675885 18964387627
Website: http://www.efebio.com
Company Name: Changzhou Xianglong Pharmaceutical Technology Co., Ltd.,  
Telephone: 18915873328 18915873328
Website: www.xianglongpharm.com/
Tags:23452-98-4 Related Product Information
35900-16-4 41692-15-3 26198-80-1 217182-28-0 57944-39-5 26441-05-4